Is the price fair?
What NOVT's price assumes
Novanta Inc. trades at 107× earnings against 32.3× for the median Scientific & Technical Instruments name, more expensive than its own group.
107
Trailing P/E · Scientific & Technical Instruments median 32.3 · 3.32× the median: the market pays up for this one
- Price / sales
- 4.79
Price / sales · as of 2026-Q1
- Free cash flow yield
- 1.2%
Free cash flow yield · Scientific & Technical Instruments median 4.0%
- Growth the price implies
- +25%
Growth the price implies · The price pays for +25% free cash flow growth a year for a decade; the business has delivered −2.0% a year over the last three.
Details›
- Price / book2026-Q1
- 3.67
- EV / EBIT2026-Q1
- 51.9
- EV / sales2026-Q1
- 4.61
- Technology median P/E365 names
- 36.5
- Scientific & Technical Instruments median P/E16 names
- 32.3
- Free cash flow, trailing twelve months
- $68M
- Market capitalisation
- $5.71B
- 3-year revenue growth
- +4.7%
- 3-year free cash flow growth
- −2.0%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $92.69 |
| Its own P/E history, median | $109.57 |
| Its own P/E history, upper quartile | $130.50 |
| 52-week range | $99.22 – $168.82 |
| Today | $149.29 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Scientific & Technical Instruments
Ranks #9 of 10 by Smart Score